No. |
Cell type |
JCRB No.
|
Cell Name
|
Animal
|
Tissue
|
Profile
|
|
1 | general cells |
IFO50069 |
Alexander cells |
human |
liver |
hepatoma, HBs antigen-positive. This cell line is the same cell line as PLF/PRF/5 (other name of PLC/PRF/5). |
|
2 | general cells |
IFO50073 |
MRC-5 |
human |
lung |
Normal diploid fibroblasts with limited life span (crisis PDL = 42-46). |
|
3 | general cells |
IFO50079 |
Flow7000 |
human |
prepuce |
Normal diploid fibroblasts with limited life span. |
|
4 | general cells |
IFO50107 |
G-292 clone A141B1 |
human |
bone |
osteosarcoma |
|
5 | general cells |
IFO50276 |
A2058 |
human |
melanoma |
malignant melanoma, metastasis to lymph node |
|
6 | general cells |
IFO50481 |
NRK-49F |
rat |
kidney |
NRK-49F is a fibroblastic clone of NRK (mixed culture of normal rat kidney) cells. (J. Bacteriol., 92, 1133 (1966)). This cell line exhibits contact inhibition and is useful for transformation assays. |
|
7 | general cells |
JCRB0144.1B |
LYM-1.P3B |
rat |
|
Serum free FAR-2.F60 rat cell culture from lymph node near colon cancer. |
|
8 | general cells |
JCRB0151.1 |
p53-def-MOSE |
mouse |
ovarian surface epitherium |
ovarian surface epithelial cell line from p53(-/-) mouse |
|
9 | general cells |
JCRB0152.1 |
M |
rat |
liver |
Cell line which is derived from RLC-3 (JAR rat) after 54 day-culture by Nagisa method with treatment of DAB(10ug/ml) for one week. Cells are capable to form collagen network. |
|
10 | general cells |
JCRB0161 |
Kasumi-4 |
human |
blood |
A novel human leukemia cell line established from a patient with chronic myelogenous leukaemia (CML) in blast crisis. |
|
11 | general cells |
JCRB0179 |
SNG-M |
human |
metastatic lymph node |
Intermedicately differentiated human adenocarcinoma cell line. |
|
12 | general cells |
JCRB0541 |
TIG-111 |
human |
skin |
Normal diploid fibroblast from human skin with limited lifespan. |
|
13 | general cells |
JCRB0542 |
TIG-120 |
human |
skin |
Normal diploid fibroblast from human skin with limited lifespan. |
|
14 | general cells |
JCRB0832 |
NH-6 |
human |
adrenal gland |
neuroblastoma, adrenal gland, opsomyoclonus, truncal ataxia |
|
15 | general cells |
JCRB1080.1 |
HARA-B |
human |
mouse bone metastasis |
HARA cell (human lung squamouse cell carcinoma) established from bone metastasis in nude mouse. |
|
16 | general cells |
JCRB1134 |
KUM3 |
mouse |
Bone marrow |
Osteoblast cell line from Mouse C3H bone marrow. |
|
17 | general cells |
JCRB1202 |
KUM6 |
mouse |
Bone marrow |
Osteoblastic cell line |
|
18 | general cells |
JCRB1345 |
PALL-2 |
human |
peripheral blood |
Ph1 chromosome-positive human acute lymphoblastic leukemia cell line. |
|
19 | general cells |
JCRB1349 |
Ex-3LL |
mouse |
|
Variant cell line possessing enhanced lung metastasis ability derived from Lewis lung cancer (3LL). |
|
20 | general cells |
JCRB1358.01 |
SRBC-P13-7-3 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
21 | general cells |
JCRB1358.04 |
SRBC-F12-1-19 |
mouse x mouse |
|
Mouse hybridoma cell line producing monoclonal antibody against sheep erythrocytes (SRBCs). |
|
22 | general cells |
JCRB1441 |
ASF-4-4L1 |
human |
skin |
Normal diploid fibroblast with limeted life span. The ASF-4-1, ASF-4-2, ASF-4-3 and the ASF-4-4 lines were established from skins of the same donor at different ages. |
|
23 | genetically-modified cells |
JCRB1458 |
HUEhT-1 |
human |
human umbilical vein |
Immortalized human umbilical vein endothelial cell line established (HUVEC) by electroporation of pIRES-hTERT-hygr. |
|
24 | general cells |
JCRB1552 |
HARA-B4 |
human |
mouse bone metastasis |
HARA cell (human lung squamouse cell carcinoma) established from bone metastasis (4 times selection) in nude mouse. |
|
25 | genetically-modified cells |
JCRB1736 |
293_hSyn1 |
human |
kidney |
293 cell line into which human Syndecan-1 gene has been transfected. |
|
26 | general cells |
JCRB1743 |
XYFMGG18B |
human |
blood |
EBV transformed B-cell lymphoblastoid cell line from human XY female. |
|
27 | general cells |
JCRB1775 |
KKK-D068 |
human |
Intrahepatic bile duct |
Human well differentiated tubular adenocarcinma cell line established from biliary tract. (with micropapillary foci) |
|
28 | general cells |
JCRB1782 |
BALM-7 |
human |
bone marrow |
B cell leukemia cell line |
|
29 | general cells |
JCRB1801 |
BALM-25 |
human |
bone marrow |
B cell leukemia cell line, ALL-L3 cell line |
|
30 | general cells |
JCRB1812 |
MOLM-14 |
human |
|
Human acute monocytic leukemia (AML-M5a) cell line. MOLM-14 was established from the same donor as MOLM-13. |
|
31 | general cells |
JCRB1928 |
Sui76 |
human |
liver metastasis |
Pancreatic adenocarcinoma. Cell line established by forming xenograft tumor (PDX) from liver metastasis. |
|
32 | genetically-modified cells |
JCRB1957 |
MDCK-dEGF_#1 |
dog |
kidney |
Epidermal growth factor (EGF)-deficient MDCK cell line.
|
|
33 | genetically-modified cells |
JCRB1968 |
MDCK-dEGF_#2 |
dog |
kidney |
Epidermal growth factor (EGF)-deficient MDCK cell line. |
|
34 | genetically-modified cells |
JCRB1996 |
MDCK-dADAM17-EKARrEV-NLS |
dog |
kidney |
A disintegrin and metalloprotease 17 (ADAM17)-deficient MDCK cell line expressing FRET biosensor EKARrEV-NLS. |
|
35 | general cells |
JCRB2210 |
A9(Bsr10) |
human chromosome-introduced |
skin |
contains human chromosome #10 (MTA with Tottori Univ. is required.) |
|
36 | genetically-modified cells |
JCRB4005 |
MDCK-4KO-EKARrEV-NLS-EGF |
dog |
kidney |
MDCK-4KO-EKARrEV-NLS expressing UbC-canisEGF. |
|
If you wish you add additional cell lines to your order, please click the "Additional order" button below.
It will close the current window and allow you to add additional cell lines to your order.
If you are ready to proceed and place your order, please click on the "Order form (SSL)" button below.